The Cooper Companies, Inc. $COO Shares Sold by Swedbank AB

25 Dec 2025, 11:14 by Mitch Edgeman · The Markets Daily

Swedbank AB trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 24.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 904,029 shares of the medical device company’s stock after selling 284,744 shares during the period. Swedbank AB owned approximately 0.45% of Cooper Companies worth $61,980,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Wealth Alliance LLC grew its position in Cooper Companies by 4.2% during the second quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company’s stock valued at $301,000 after acquiring an additional 171 shares during the period. State of Michigan Retirement System grew its holdings in shares of Cooper Companies by 0.4% during the 2nd quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company’s stock worth $3,867,000 after purchasing an additional 200 shares during the period. New York Life Investment Management LLC grew its holdings in shares of Cooper Companies by 0.7% during the 2nd quarter. New York Life Investment Management LLC now owns 30,019 shares of the medical device company’s stock worth $2,136,000 after purchasing an additional 210 shares during the period. Hardy Reed LLC increased its position in Cooper Companies by 4.1% during the 2nd quarter. Hardy Reed LLC now owns 6,213 shares of the medical device company’s stock worth $442,000 after purchasing an additional 244 shares in the last quarter. Finally, Private Trust Co. NA raised its holdings in Cooper Companies by 25.2% in the second quarter. Private Trust Co. NA now owns 1,278 shares of the medical device company’s stock valued at $91,000 after buying an additional 257 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 0.7%

Shares of NASDAQ COO opened at $82.32 on Thursday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $100.24. The stock’s 50-day simple moving average is $75.49 and its 200-day simple moving average is $72.30. The firm has a market cap of $16.13 billion, a price-to-earnings ratio of 43.79, a PEG ratio of 2.36 and a beta of 1.05.

Cooper Companies (NASDAQ:COO – Get Free Report) last issued its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the business posted $1.04 earnings per share. Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a stock buyback plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to buy up to 15.4% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

Positive Sentiment: Experienced board addition — CooperCompanies appointed Walter M. Rosebrough Jr., former STERIS CEO, as an independent director effective Jan. 3, 2026. His track record in medical devices and the Board’s pledge to consider him for Chair by end‑2026 are being viewed as a credibility and governance upgrade that could support strategic execution. CooperCompanies Appoints Walter M Rosebrough, Jr to its Board of Directors
Positive Sentiment: Insider buying — Director Cynthia L. Lucchese bought 1,784 shares at ~$84.06 on Dec. 22, increasing her stake ~23%. Recent insider purchases are often read as confidence signals and can support sentiment while the market evaluates governance changes. SEC Filing — Insider Purchase
Neutral Sentiment: Cooperation agreement and filings — The Company entered a cooperation agreement with Browning West, which includes standstill/voting commitments and an 8‑K disclosure. These formalize the arrangement but don’t immediately change fundamentals; investors should read the filed agreement for specifics on governance and timing. Press Release / 8‑K Disclosure
Neutral Sentiment: Short‑interest data appears unreliable — a December entry shows “0 shares” and NaN changes; treat that as a data anomaly rather than a market signal until exchanges/feeds correct the figure.
Negative Sentiment: Activist/uncertainty risk — Browning West’s involvement signals prior shareholder dissatisfaction. While cooperative now, the process of board refresh, potential shifts in capital allocation or strategic priorities, and transition risk can create short‑term volatility until execution clarity arrives. Quiver Quant — Cooperation Agreement Summary

Insider Buying and Selling at Cooper Companies

In related news, Director Maria Rivas acquired 1,000 shares of the firm’s stock in a transaction on Thursday, December 18th. The stock was bought at an average cost of $82.13 per share, with a total value of $82,130.00. Following the acquisition, the director directly owned 11,141 shares in the company, valued at approximately $915,010.33. The trade was a 9.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Cynthia L. Lucchese bought 1,784 shares of the company’s stock in a transaction dated Monday, December 22nd. The stock was bought at an average cost of $84.06 per share, with a total value of $149,963.04. Following the transaction, the director directly owned 9,445 shares in the company, valued at approximately $793,946.70. The trade was a 23.29% increase in their position. The SEC filing for this purchase provides additional information. In the last three months, insiders have acquired 18,014 shares of company stock valued at $1,441,196. Corporate insiders own 1.98% of the company’s stock.

Analysts Set New Price Targets

COO has been the subject of several research reports. Robert W. Baird boosted their price objective on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research note on Friday, December 5th. JPMorgan Chase & Co. upped their price target on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research report on Friday, December 5th. Piper Sandler reiterated an “overweight” rating and issued a $94.00 price target (up from $83.00) on shares of Cooper Companies in a report on Friday, December 5th. Stifel Nicolaus set a $95.00 price objective on Cooper Companies and gave the stock a “buy” rating in a research note on Friday, December 5th. Finally, Citigroup reaffirmed a “neutral” rating and issued a $88.00 target price (up previously from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and an average price target of $90.15.

Read Our Latest Research Report on COO

Cooper Companies Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.